Lv4
560 积分 2022-04-27 加入
RAS-Mutant Follicular Thyroid Tumors: A Continuous Challenge for Pathologists
5天前
已完结
Somatic DICER1-Mutant Benign Thyroid Nodules in Adults: A Group of Follicular Nodular Disease With Continuous Growth
6天前
已完结
High Rates of Unnecessary Surgery for Indeterminate Thyroid Nodules in the Absence of Molecular Test and the Cost-Effectiveness of Utilizing Molecular Test in an Asian Population: A Decision Analysis
8天前
已完结
High Rates of Unnecessary Surgery for Indeterminate Thyroid Nodules in the Absence of Molecular Test and the Cost-Effectiveness of Utilizing Molecular Test in an Asian Population: A Decision Analysis
9天前
已完结
Alectinib for the treatment of papillary thyroid carcinoma harbouring STRN – ALK fusion
9天前
已完结
Response: Letter to the editor: “Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular Screening and Therapeutics (MoST) program”
9天前
已完结
Wnt/B-catenin activation and TP53 mutations associate with distinct immune profiles in advanced thyroid cancer
9天前
已完结
Radioactive Iodine Therapy in Differentiated Thyroid Cancer: Summary of the Korean Thyroid Association Guidelines 2024 from Nuclear Medicine Perspective, Part-II
9天前
已完结
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions
9天前
已完结
Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies
9天前
已完结
皖公网安备34019202002308
